Here are relevant reports on : automated-insulin-delivery-systems-market
-
Proteins & Protein Crystals Market by Product Type (Enzyme, Monoclonal Antibodies, Insulin, Hormones); Structural (Membrane, Matrix), Specialty (Nutrition, Analytics, Cosmetics); Application (Healthcare, Environmental); End User (Pharma, Biotech, CROs) - Global Forecast to 2030
The global proteins & protein crystals market, valued at US$557.00 billion in 2024, stood at US$609.51 billion in 2025 and is projected to advance at a resilient CAGR of 9.5% from 2025 to 2030, culminating in a forecasted valuation of US$960.37 billion by the end of the period. The growth of the proteins & protein crystals market is fueled by rising demand for biologics and protein-based medicines, continuous technological improvements in crystallization techniques, and increased research spending in biopharmaceuticals and drug discovery.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Hospitals & Self/Home Healthcare) - Global Forecast to 2028
The global digital diabetes management market, valued at US$16.3 billion in 2022, stood at US$18.9 billion in 2023 and is projected to advance at a resilient CAGR of 13.6% from 2023 to 2028, culminating in a forecasted valuation of US$35.8 billion by the end of the period. The demand for better diabetes care solutions has grown of greater significance as diabetes prevalence has increased.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Safety Syringes Market by Technology (Retractable, Non-Rectractable, Sliding Needle, Sheathing Tube, Hinged Needle), Threapy (Insulin, Tuberculosis), Type (Attached Needle, Detachable Needles) - Analysis & Global Forecast to 2019
Safety syringes are equipped with an inbuilt safety mechanism and needles that detachable or permanently attached. The safety mechanism is designed to protect healthcare workers from accidental needlestick injuries. The global safety syringes market is expected to show considerable growth during the forecast period. This is attributed to rising incidence of needlestick injuries, government initiative to incorporate the use of safety syringes in the legislation, favorable reimbursement policies, and enhanced safety mechanisms for syringes. Several countries have introduced regulations to ensure the compulsory use of safety syringes with an aim of decreasing to needle stick injuries and prevent needle re-use. These regulations are expected to cause more common usage of safety syringes as compared to conventional syringes. However factors such as alternative drug delivery methods and high cost are limiting the growth of this market. In addition, the lack of awareness regarding healthcare and safety issues in emerging economies has restricted the market growth in the region.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024
The market for infusion pump software is expected to grow USD 1,044 million by 2024, at a CAGR of 7.1% during the forecast period. The major vendors in the global infusion pump software market are BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The Europe digital diabetes management market, valued at USD 6.89 billion in 2025, stood at USD 7.78 billion in 2026 and is projected to advance at a resilient CAGR of 10.0% from 2026 to 2031, culminating in a forecasted valuation of USD12.53 billion by the end of the period. Europe is a significant enabler of digital diabetes management. These devices generate continuous, real-time data that can be integrated into digital platforms for monitoring, alerts, and personalized insights.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Latin America Infusion Pump Market by Product (Accessories & Consumables, Devices (Volumetric, Insulin, Syringe, Ambulatory, PCA)), Application (Chemotherapy, Diabetes, Analgesia, Pediatrics, Hematology), End User (Hospitals) - Global Forecast to 2030
The global Latin America infusion pumps market, valued at US$707.6 million in 2024, stood at US$743.7 million in 2025 and is projected to advance at a resilient CAGR of 6.2% from 2025 to 2030, culminating in a forecasted valuation of US$1,004.9 million by the end of the period. The Latin America infusion pumps market is growing rapidly due to increasing healthcare awareness and improved access to advanced medical technologies across the region.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030
The global wearable healthcare devices market, valued at US$41.07 billion in 2024, stood at US$45.29 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$75.98 billion by the end of the period. Market growth is driven by rising health awareness, a shift toward preventive care, and the increasing prevalence of chronic conditions in aging populations.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030
The global infusion pump market, valued at US$18.5 billion in 2024, stood at US$19.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$ 28.3 billion by the end of the period. The infusion pump market is expanding rapidly, driven by significant technological advancements in smart, interconnected, and automated systems that optimize the precision and safety of infusion therapy.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
US Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The US digital diabetes management market, valued at US$11.19 billion in 2025, stood at US$12.94 billion in 2026 and is projected to advance at a resilient CAGR of 11.9% from 2026 to 2031, culminating in a forecasted valuation of US$22.67 billion by the end of the period. The growth of the US digital diabetes management market is driven by the integration of AI-driven analytics, telehealth platforms, and interoperable ecosystems, which enhance clinical outcomes and patient engagement.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
